Last Update Time: 04-Mar-2025 16:00:00
ISIN: INE071N01016
Sector: Chemicals
Symbol: EPIGRAL

Epigral Limited

₹1,723.00 ₹167.75 (10.79%) ▲
Prev. Close ₹1,555.25
Open ₹1,555.25
Close ₹1,711.00
Range ₹1,636.85 - ₹1,809.15
High ₹1,726.10
Low ₹1,529.60
Ind. Close ₹0.00
VWAP ₹1,680.34

The current stock price of Epigral Limited is ₹1,723.00, with a target price range between ₹1,636.85 and ₹1,809.15. The stock has experienced a price change of ₹167.75 (10.79%), reflecting recent market volatility.

Today's opening price was ₹1,555.25, while the previous close stood at ₹1,555.25.

The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.

For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.

Epigral Limited Price Chart

Epigral Limited Pre Open Market Overview: 04-Mar-2025

Key Metrics:

  • IEP (Indicative Equilibrium Price): 1555.25
  • Previous Close Price: 1555.25
  • Change: 0.00%
  • Total Traded Volume: 368
  • Total Buy Quantity: 872
  • Total Sell Quantity: 182
PriceBuy QtySell Qty
1,533.7020.000.00
1,545.002.000.00
1,547.008.000.00
1,551.0030.000.00
1,555.2587.000.00
1,557.000.0055.00
1,561.000.002.00
1,563.000.0016.00
1,570.750.003.00
1,575.000.001.00

ATO Data:

  • Buy Quantity (ATO): 0
  • Sell Quantity (ATO): 0

Order Book

BidQtyAskQty
0.0000.000
0.0000.000
0.0000.000
0.0000.000
0.0000.000
Total Buy Quantity: 872 Total Sell Quantity: 182

Shareholding Patterns of Epigral Limited

Key Trade Statistics of Epigral Limited

Trade InformationDetails
Traded Volume (Lakhs)1.26
Traded Value (₹ Cr.)21.20
Total Market Cap (₹ Cr.)7,433.25
Free Float Market Cap (₹ Cr.)2,306.12
Impact cost0.09
Quantity Traded126,161.00
Deliverable Quantity32,823.00
% of Quantity to Traded26.02
Security VaR21.52
Index VaRN/A
VaR Margin21.52
Extreme Loss Rate3.5
Adhoc MarginN/A
Applicable Margin Rate25.02
Face Value10

Key Price Statistics of Epigral Limited

The 52-week high for Epigral Limited was ₹2,406.75, recorded on 03-Oct-2024. On the other hand, the 52-week low stands at ₹950.25, with the lowest value recorded on 15-Mar-2024.

The upper band for trading is ₹1,866.30, and the lower band is ₹1,244.20. The price band is 20%.

The stock's daily volatility stands at 3.25, while the annualized volatility is 62.09. The tick size for trading is ₹0.05.

Price InformationDetails
52 Week High (03-Oct-2024)2,406.75
52 Week Low (15-Mar-2024)950.25
Upper Band1,866.30
Lower Band1,244.20
Price Band (%)20
Daily Volatility3.25
Annualised Volatility62.09
Tick Size0.05

Key Securities Statistics of Epigral Limited

Securities InformationDetails
StatusListed
Trading StatusActive
Date of Listing18-Aug-2021
Adjusted P/E19.35
Symbol P/E19.35
IndexNIFTY TOTAL MARKET
Macro-Economic SectorCommodities
SectorChemicals
IndustryChemicals & Petrochemicals
Basic IndustrySpecialty Chemicals

Security Status of Epigral Limited

TitleDetails
Board StatusMain
Trading SegmentNormal Market
Session No.-
Class of SharesEquity
SDD Compliance-
Name of Compliance Officer-

Announcements of Epigral Limited

SubjectDate
Analysts/Institutional Investor Meet/Con. Call Updates 01-Mar-2025
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent 28-Feb-2025
Cessation 28-Feb-2025
Appointment 28-Feb-2025
Analysts/Institutional Investor Meet/Con. Call Updates 06-Feb-2025
Analysts/Institutional Investor Meet/Con. Call Updates 31-Jan-2025
Analysts/Institutional Investor Meet/Con. Call Updates 30-Jan-2025
Copy of Newspaper Publication 28-Jan-2025

Corporate Actions of Epigral Limited

Face ValuePurposeEx-DateStart DateEnd Date
10Interim Dividend - Rs 2.50 Per Share07-Feb-2025--
10Annual General Meeting/Dividend - Rs 5 Per Share02-Jul-2024--
10Dividend - Rs 2.50 Per Share20-Jun-2023--
10Annual General Meeting20-Jun-202321-Jun-202327-Jun-2023
10Interim Dividend - Rs 2.50 Per Share01-Feb-2023--
10Annual General Meeting17-Jun-202221-Jun-202227-Jun-2022
10 Annual General Meeting15-Sep-202117-Sep-202123-Sep-2021

Board Meetings of Epigral Limited

PurposeDetailsAtt.Mtg. Date
Board Meeting IntimationEPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 27-Jan-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Dividend. 27-Jan-2025
Financial Results/DividendTo consider and approve the financial results for the period ended December 31, 2024 and dividend 27-Jan-2025
Board Meeting IntimationEPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . 09-Nov-2024
Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024 09-Nov-2024
EPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2024 to consider Fund raising.Board Meeting Intimation 14-Aug-2024
Fund RaisingTo consider Fund Raising 14-Aug-2024
Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2024 24-Jul-2024
EPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 24-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .Board Meeting Intimation 24-Jul-2024
EPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 22-Apr-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend.Board Meeting Intimation 22-Apr-2024
Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2024 and dividend 22-Apr-2024
EPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 24-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .Board Meeting Intimation 24-Jan-2024
Financial ResultsTo consider and approve the financial results for the period ended December 31, 2023 24-Jan-2024
EPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .Board Meeting Intimation 06-Nov-2023
Financial ResultsTo consider and approve the financial results for the period ended September 30, 2023 06-Nov-2023
MEGHMANI FINECHEM LIMITED has informed the Exchange about Board Meeting to be held on 05-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 .Board Meeting Intimation 05-Aug-2023
Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2023 05-Aug-2023
Financial Results/DividendIntimation of the Board Meeting of Meghmani Finechem Limited scheduled to be held on Tuesday, 25th April, 2023 for consideration & approval of Audited Financial Results and recommendation of Final Dividend, if any. 25-Apr-2023
MEGHMANI FINECHEM LIMITED has informed the Exchange about Board Meeting to be held on 25-Apr-2023 to consider financial statements for the period ended March 2023, Financial results/Dividend.Board Meeting Intimation 25-Apr-2023
Financial Results/DividendTo consider and approve the financial results for the period ended December 31, 2022 and dividend 19-Jan-2023
Financial resultsMeghmani Finechem Limited has informed the Exchange about Board Meeting to be held on 20-Oct-2022 to consider unaudited financial statements for the period ended September 2022 20-Oct-2022

Financial Results of Epigral Limited

Company Directory of Epigral Limited

Web AddressSM NameOfficeAddressCityPincodeTelephoneEmail
N/AEpigral LimitedHead Office/ Corporate OfficeMEGHMANI HOUSE
B/H, SAFAL PROFITAIRE
CORPORATE ROAD
PRAHLADNAGAR
AHMEDABAD380015079-9825005768kamlesh.mehta@meghmani.com
N/AEpigral LimitedRegistered OfficeEpigral Tower, B/h. Safal Profitaire,
Corporate Road, Prahladnagar,
Ahmedabad,
AHMEDABAD38001579-9920412444gaurang.trivedi@epigral.com
N/AEpigral LimitedTransfer AgentLink Intime India Pvt. Ltd., C-101, 247 Park,
LBS.Marg, Vikhroli (West),
MUMBAI
MUMBAI400083022-02249186060NILESH.DALWADI@linkintime.co.in

Insider Trading of Epigral Limited

Reg. ClauseAcq./Disp.Sec. (No.)Sec. ValueTxn TypeBcast Time
7(2)RAMESHBHAI MEGHJIBHAI PATEL50004837838Buy05-Jun-2023 18:03
7(2)RAMESHBHAI MEGHJIBHAI PATEL50004602296Buy01-Jun-2023 21:30
7(2)MAULIK JAYANTIBHAI PATEL800719049Buy20-Mar-2023 13:07
7(2)MAULIK JAYANTIBHAI PATEL20001778388Buy17-Mar-2023 15:03
7(2)MAULIK JAYANTIBHAI PATEL45004284811Buy16-Mar-2023 15:33
7(2)MAULIK JAYANTIBHAI PATEL50004838333Buy15-Mar-2023 15:06
7(2)MAULIK JAYANTIBHAI PATEL12821313602Buy07-Mar-2023 13:13
7(2)MAULIK JAYANTIBHAI PATEL20001986354Buy01-Mar-2023 15:58
7(2)MAULIK JAYANTIBHAI PATEL50005064450Buy28-Feb-2023 12:13
7(2)MAULIK JAYANTIBHAI PATEL38003981903Buy22-Feb-2023 11:25
7(2)MAULIK JAYANTIBHAI PATEL13901452672Buy20-Feb-2023 14:13
7(2)MAULIK JAYANTIBHAI PATEL16001658912Buy16-Feb-2023 11:11
7(2)MAULIK JAYANTIBHAI PATEL16001658912Buy16-Feb-2023 11:11
7(2)MAULIK JAYANTIBHAI PATEL27602853618Buy15-Feb-2023 18:14
7(2)RAMESHBHAI MEGHJIBHAI PATEL48005013282Buy27-Jan-2023 14:41
7(2)DHIREN MADHUR GOYAL1000761280Buy23-Mar-2022 14:31
7(2)KRUTI ADESH PATEL500395486Buy23-Mar-2022 14:28
7(2)ADESH KIRITKUMAR PATEL500395486Buy23-Mar-2022 14:25
7(2)KAUSHAL ASHISHBHAI SOPARKAR1000799038Buy09-Mar-2022 15:08
7(2)KAUSHAL ASHISHBHAI SOPARKAR427314087Buy22-Dec-2021 12:17

Annual Reports of Epigral Limited

CompanyFrom YearTo YearAtt.
Epigral Limited20232024
Epigral Limited20222023
Epigral Limited20212022
Epigral Limited20202021

Investor Complaints of Epigral Limited

Event Calendar of Epigral Limited

CompanyPurposeDetailsDate
Epigral LimitedFinancial ResultsTo consider and approve the financial results for the period ended September 30, 202126-Oct-2021
Epigral LimitedFinancial ResultsTo consider and approve the financial results for the period ended December 31, 202124-Jan-2022
Epigral LimitedOther business mattersRevised Intimation for additional agenda to shift Registered Office of the Company to be considered at the Board Meeting of Meghmani Finechem Limited to be held on Monday, 24th January, 2022.24-Jan-2022
Epigral LimitedFinancial resultsMeghmani Finechem Limited has informed the Exchange about Board Meeting to be held on 25-Apr-2022 to consider financial statements for the period ended March 202225-Apr-2022
Epigral LimitedFinancial resultsMeghmani Finechem Limited has informed the Exchange about Board Meeting to be held on 21-Jul-2022 to consider financial statements for the period ended on 30 June 202221-Jul-2022
Epigral LimitedFinancial resultsMeghmani Finechem Limited has informed the Exchange about Board Meeting to be held on 20-Oct-2022 to consider unaudited financial statements for the period ended September 202220-Oct-2022
Epigral LimitedFinancial Results/DividendTo consider and approve the financial results for the period ended December 31, 2022 and dividend19-Jan-2023
Epigral LimitedFinancial Results/DividendIntimation of the Board Meeting of Meghmani Finechem Limited scheduled to be held on Tuesday, 25th April, 2023 for consideration & approval of Audited Financial Results and recommendation of Final Dividend, if any.25-Apr-2023
Epigral LimitedFinancial ResultsTo consider and approve the financial results for the period ended Jun 30, 202305-Aug-2023
Epigral LimitedFinancial ResultsTo consider and approve the financial results for the period ended September 30, 202306-Nov-2023
Epigral LimitedFinancial ResultsTo consider and approve the financial results for the period ended December 31, 202324-Jan-2024
Epigral LimitedFinancial Results/DividendTo consider and approve the financial results for the period ended March 31, 2024 and dividend22-Apr-2024
Epigral LimitedFinancial ResultsTo consider and approve the financial results for the period ended Jun 30, 202424-Jul-2024
Epigral LimitedFund RaisingTo consider Fund Raising14-Aug-2024
Epigral LimitedFinancial ResultsTo consider and approve the financial results for the period ended September 30, 202409-Nov-2024
Epigral LimitedFinancial Results/DividendTo consider and approve the financial results for the period ended December 31, 2024 and dividend27-Jan-2025

Share Transfers of Epigral Limited

CompanyPeriodReg.7Reg.40Reg7 Bcast DateReg40 Bcast Date
Epigral Limited31-MAR-2024 09-Apr-2024 13:50:0318-Apr-2024 11:50:06

Voting Results of Epigral Limited

Date of Mtg.Mtg. TypeResolutionR. requiredTotal SHs% favour% against
16-SEP-2024Postal BallotTo approve fund raising by way of issuance of equity shares and/or equity linked securities for an aggregate amount up to Rs. 500 Crore. nSpecial8801799.840.16
09-JUL-2024AGM(a): To receive, consider, and adopt the Audited Standalone Financial Statement of the Company for the Financial Year ended on 31st March, 2024 together with reports of the Board of Directors & Auditors thereon; and (b): To receive, consider, and adopt the Audited Consolidated Financial Statement of the Company. nfor the Financial Year ended on 31st March, 2024 together with reports of Auditors thereon.Ordinary873331000
09-JUL-2024AGMTo declare a final dividend of Rs 5/- (50%) per equity share of Rs. 10/- each for the Financial Year 2023- 2024.Ordinary873331000
09-JUL-2024AGMTo appoint a director in place of Mr. Ankit Patel (DIN 02180007), who retires by rotation, and being eligible, offers himself for re-appointment.Ordinary8733399.950.05
09-JUL-2024AGMTo appoint a Director in place of Mr. Karana Patel (DIN 01727321), who retires by rotation, and being eligible, offers himself for re-appointment.Ordinary8733399.950.05
09-JUL-2024AGMRatification of Appointment of Statutory Auditors.Ordinary873331000
09-JUL-2024AGMRatification of remuneration payable to Cost Auditors of the Company for the financial year 2024-25.Ordinary873331000
09-JUL-2024AGMContinuation of Mr. Manubhai Khodidas Patel as a Non-Executive Independent Director of the Company on completion of 75 years of age.Special8733399.830.17

FAQs on Epigral Limited

Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.